Glenn Saldanha is the Managing Director & CEO of Glenmark Pharmaceuticals Limited. Glenn joined Glenmark Pharmaceuticals in 1998 as Director and took over as Managing Director & CEO in 2001.

As MD & CEO of Glenmark Pharmaceuticals Limited, Glenn Saldanha oversees the entire operations of the organization. During his tenure, he has managed to transform Glenmark from an Indian-driven branded generics business into a research-driven innovation-led organization that focuses on discovering new molecules. Simultaneously he has built a strong branded formulations business across emerging economies including India and has also established a strong foothold in the US generics market in a short period.

Mr. Saldanha holds a Bachelor’s Degree in Pharmacy from Mumbai University and is an MBA from Leonard Stern School of Business, New York University. Prior to Glenmark, Mr. Saldanha has worked with Eli Lily, USA and PriceWater House Coopers, USA.

Having over 20 years of experience in the pharmaceutical field, she presently heads the company’s Human Resource, Administration functions. As an entrepreneur Cheryl was the founder of a pharmaceutical company which she served as Managing Director from 1989 to 1999 before joining Glenmark.

Cheryl is a Graduate in Pharmacy from the University Department of Chemical Technology in Mumbai. She has also completed The General Management Programme from the Harvard Business School in Boston.

Mr. D. R. Mehta, holds a Bachelors Degree in Arts and an LLB degree from the Rajasthan University. He also holds a Management Degrees from Royal Institute of Public Administration, London and from Alfred Sloan School of Management, Massachusetts Institute of Technology, Boston, United States of America. He was a civil servant for almost forty years and has experience in administration and management of public affairs. He joined the Indian Administrative Services in 1961 and has held positions in the
Government of Rajasthan and in the Government of India. He served in the Government of Rajasthan as ‘Collector’ for three districts and Secretary of various departments like Industry, Mines and State enterprises. He was the Joint Secretary (Banking), Controller of Capital Issues and Additional Secretary (Banking) in the Ministry of Finance, Government of India.

He was also the Secretary of the Committee on Financial Policy in the cabinet secretariat in the Government of India. Further, he was the Director General of Foreign Trade in the Government of India, Ministry of Commerce. He was also the Deputy Governor of the Reserve Bank of India and the Chairman of SEBI. He was also the Chairman of the Emerging Markets Committee of the International Organization of Securities Commission

Mr. Hocine Sidi Said, is the Founder and Director of Bio-nAbler, an investment company that partners with Sovereign Wealth Funds and Private Equity Firms across Asia and the MENA region to identify and execute product & company acquisitions.  He has spent over 20 years in the pharmaceutical industry at Pfizer and UCB. He has led the Emerging Markets Region at UCB as their Senior Vice President.  Prior to Joining UCB, Hocine spent close to 17 years with Pfizer in various senior management and business development roles in the Middle East, Central and Eastern Europe and Asia